These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24509510)

  • 1. Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia.
    Joshi I; Yoshida T; Jena N; Qi X; Zhang J; Van Etten RA; Georgopoulos K
    Nat Immunol; 2014 Mar; 15(3):294-304. PubMed ID: 24509510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific control of early B cell development by the transcription factor Ikaros.
    Schwickert TA; Tagoh H; Gültekin S; Dakic A; Axelsson E; Minnich M; Ebert A; Werner B; Roth M; Cimmino L; Dickins RA; Zuber J; Jaritz M; Busslinger M
    Nat Immunol; 2014 Mar; 15(3):283-93. PubMed ID: 24509509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.
    Hu Y; Zhang Z; Kashiwagi M; Yoshida T; Joshi I; Jena N; Somasundaram R; Emmanuel AO; Sigvardsson M; Fitamant J; El-Bardeesy N; Gounari F; Van Etten RA; Georgopoulos K
    Genes Dev; 2016 Sep; 30(17):1971-90. PubMed ID: 27664237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ikaros fingers on lymphocyte differentiation.
    Yoshida T; Georgopoulos K
    Int J Hematol; 2014 Sep; 100(3):220-9. PubMed ID: 25085254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
    Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
    Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation.
    Ferreirós-Vidal I; Carroll T; Taylor B; Terry A; Liang Z; Bruno L; Dharmalingam G; Khadayate S; Cobb BS; Smale ST; Spivakov M; Srivastava P; Petretto E; Fisher AG; Merkenschlager M
    Blood; 2013 Mar; 121(10):1769-82. PubMed ID: 23303821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.
    Bond J; Domaschenz R; Roman-Trufero M; Sabbattini P; Ferreiros-Vidal I; Gerrard G; Asnafi V; Macintyre E; Merkenschlager M; Dillon N
    Oncotarget; 2016 Oct; 7(40):65923-65936. PubMed ID: 27588474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional circuits in B cell transformation.
    Hu Y; Yoshida T; Georgopoulos K
    Curr Opin Hematol; 2017 Jul; 24(4):345-352. PubMed ID: 28463873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
    Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals.
    Heizmann B; Kastner P; Chan S
    J Exp Med; 2013 Dec; 210(13):2823-32. PubMed ID: 24297995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
    Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.
    Gowda C; Song C; Kapadia M; Payne JL; Hu T; Ding Y; Dovat S
    Adv Biol Regul; 2017 Jan; 63():71-80. PubMed ID: 27666503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ikaros antagonizes DNA binding by STAT5 in pre-B cells.
    Heizmann B; Le Gras S; Simand C; Marchal P; Chan S; Kastner P
    PLoS One; 2020; 15(11):e0242211. PubMed ID: 33180866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.
    Erasmus MF; Matlawska-Wasowska K; Kinjyo I; Mahajan A; Winter SS; Xu L; Horowitz M; Lidke DS; Wilson BS
    Sci Signal; 2016 Nov; 9(456):ra116. PubMed ID: 27899526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
    Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
    J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels.
    Kano G; Morimoto A; Takanashi M; Hibi S; Sugimoto T; Inaba T; Yagi T; Imashuku S
    Leuk Lymphoma; 2008 May; 49(5):965-73. PubMed ID: 18464116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the Ikaros 6 isoform is restricted to t(4;11) acute lymphoblastic leukaemia in children and infants and has a role in B-cell survival.
    Ruiz A; Jiang J; Kempski H; Brady HJ
    Br J Haematol; 2004 Apr; 125(1):31-7. PubMed ID: 15015965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.
    Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
    Swaminathan S; Huang C; Geng H; Chen Z; Harvey R; Kang H; Ng C; Titz B; Hurtz C; Sadiyah MF; Nowak D; Thoennissen GB; Rand V; Graeber TG; Koeffler HP; Carroll WL; Willman CL; Hall AG; Igarashi K; Melnick A; Müschen M
    Nat Med; 2013 Aug; 19(8):1014-22. PubMed ID: 23852341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.